Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

BACKGROUND: To determine the protective effects of memantine on cognitive function in patients receiving whole-brain radiotherapy (WBRT). METHODS: Adult patients with brain metastases received WBRT and were randomized to receive placebo or memantine (20 mg/d), within 3 days of initiating radiotherap...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Brown, Paul D., Pugh, Stephanie, Laack, Nadia N., Wefel, Jeffrey S., Khuntia, Deepak, Meyers, Christina, Choucair, Ali, Fox, Sherry, Suh, John H., Roberge, David, Kavadi, Vivek, Bentzen, Soren M., Mehta, Minesh P., Watkins-Bruner, Deborah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3779047/
https://ncbi.nlm.nih.gov/pubmed/23956241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not114
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller